M. Fernández

A Phase I dose escalation of combination chemotherapy with granulocyte‐macrophage–colony stimulating factor in patients with neuroblastoma

K. Matthay, M. Krailo, Mark D. Krailo, 2000, Cancer.

Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)

E. González-Barca, Marcos González, M. Sánchez-Beato, 2021, PloS one.